-
Melanoma_C32_ENU_resistance_to_Combination_Therapy
Study
EGAS00001001614
-
RNA_seq_analysis_of_transcriptome_variation_with_human_ESC_subclones
Study
EGAS00001001655
-
Genome-wide genetic and epigenetic dataset of pancreatic acinar cell carcinomas
Study
EGAS00001002533
-
The DNA methylation landscape of glioblastoma disease progression shows extensive heterogeneity in time and space
Study
EGAS00001002538
-
Inhibiton of the GABPB1L-containing GABP tetramer is sufficient to reverse replicative immortality in TERT promoter mutant glioblastoma cells.
Study
EGAS00001002582
-
Systematic kinase inhibitor profiling identifies CDK9 as a synthetic lethal target in NUT midline carcinoma
Study
EGAS00001002588
-
The exomic landscape of t(14,18) negative diffuse follicular lymphoma with 1p36 deletion
Study
EGAS00001002594
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 1).
Study
EGAS00001002630
-
Spatio-temporal evolution of the primary glioblastoma genome (newly added after 2015)
Study
EGAS00001001800
-
Genetic and Functional Drivers of Diffuse Large B Cell Lymphoma
Study
EGAS00001002606
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__clear_cell_renal_cell_carcinoma
Study
EGAS00001002608
-
Identification of a Fumarate-Hydratase Deficient-like RCC Subtype with Convergent Pathway Alterations
Study
EGAS00001002646
-
Detection of clinically relevant genetic and transcriptomic landscape in DLBCL uniformly treated by R-CHOP
Study
EGAS00001002657
-
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions(H021/INF)
Study
EGAS00001006939
-
WGS of 32 paired SRCC samples
Study
EGAS00001002668
-
Gut microbiome modulates response to anti PD1 immunotherapy in metastatic melanoma patients
Study
EGAS00001002698
-
Whole exome sequencing of cell-free DNA reveals temporo-spatial heterogeneity and identifies treatment-resistant clones in neuroblastoma
Study
EGAS00001002705
-
Aggressive genomic features in clinicallyindolent primary HHV8-negative effusion-based lymphoma
Study
EGAS00001002743
-
Spatial tumor microenvironment characterization and outcome of relapsed/refractory classic Hodgkin lymphoma
Study
EGAS00001007261
-
UCSF Pediatric Bithalamic Glioma Genome Project
Study
EGAS00001004033
-
Defective T-cell expansion in RASGRP1 deficiency
Study
EGAS00001002753
-
ALK_inhibitors_in_the_context_of_ALK_dependent_cancer_cell_lines
Study
EGAS00001000082
-
Cancer sequencing for somatic variant calling
Study
EGAS00001007101
-
Colorectal adenomas and carcinomas NKI-AvL TGO series Gut2009
Study
EGAS00001002758
-
Mutational spectrum of highly differentiated, fusion-negative rhabdomyosarcoma (set 2).
Study
EGAS00001002771
-
GBM cancer stem cell lines -RNA-seq and WGS data
Study
EGAS00001003700
-
An Empirical Approach Leveraging Tumorgrafts to Dissect the Tumor Microenvironment in Renal Cell Carcinoma Identifies Missing Link to Prognostic Inflammatory Factors
Study
EGAS00001002786
-
DERMATLAS__Tubular_adenoma
Study
EGAS00001006686
-
Preferential infiltration of distinct Vγ9δ2 T cells into Glioblastoma multiforme
Study
EGAS00001002790
-
Molecular_characterization_of_invasive_lobular_carcinoma
Study
EGAS00001000292
-
Capture Hi-C on Hodgkin lymphoma cell line L-428
Study
EGAS00001003032
-
Chordoma_Extension__known_cancer_genes_
Study
EGAS00001000895
-
Exome sequencing of HCV+ lymphoma
Study
EGAS00001006860
-
Integrative genomic profiling of hepatocellular adenomas reveals recurrent FRK activating mutations and mutational processes of malignant transformation
Study
EGAS00001000679
-
Chordoma_Exome_Sequencing
Study
EGAS00001000188
-
Radiotherapy_induced_Sarcoma_exome
Study
EGAS00001000194
-
Breast_Cancer_Exome_Resequencing
Study
EGAS00001000207
-
ICGC Oesophageal adenocarcinoma - Barrett's samples
Study
EGAS00001000726
-
Barcelona_kids_with_melanoma
Study
EGAS00001000733
-
Genetic landscape of pediatric ependymoma
Study
EGAS00001000254
-
The_genomic_architecture_of_mesothelioma_
Study
EGAS00001000353
-
Clinical activity and molecular correlates of response to atezolizumab alone or in combination with bevacizumab versus sunitinib in renal cell carcinoma
Study
EGAS00001002928
-
Mechanisms_of_patient_response_to_Dabrafenib_in_Melanoma
Study
EGAS00001000946
-
Targeted sequencing of head and neck squamous cell carcinomas
Study
EGAS00001002979
-
RNAseq of Follicular Lymphoma
Study
EGAS00001002980
-
Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial
Study
EGAS00001007421
-
Angiosarcoma_whole_exome
Study
EGAS00001000588
-
PLCG1 R707Q mutation is counter selected under targeted therapy in a patient with a hepatic angiosarcoma
Study
EGAS00001001281
-
POT1_splice_site_mutant_analysis
Study
EGAS00001000571
-
Whole genome sequencing of tumour and normal paired samples of diffuse intrinsic pontine gliomas
Study
EGAS00001000572
-
The evolutionary history of human colitis-associated colorectal cancer
Study
EGAS00001003028
-
Exome-wide analysis identifies three low-frequency missense variants associated with pancreatic cancer risk in Chinese populations
Study
EGAS00001003040
-
Angiosarcoma_RNA_sequencing
Study
EGAS00001000590
-
Whole genome and transcriptome analysis of anaplastic thyroid carcinoma
Study
EGAS00001001214
-
CCND1-negative MCL
Study
EGAS00001003060
-
Mutational_Signatures_of_relapse_in_rectal_cancer_FFPE_samples_in_the_CR07_clinical_trial
Study
EGAS00001000651
-
Exome_sequencing_of_EBV_driven_lymphoma
Study
EGAS00001001021
-
Germline variants in patients diagnosed with both uveal and cutaneous melanoma
Study
EGAS00001007584
-
Ewings Sarcoma RNA-Seq
Study
EGAS00001003062
-
RNA-seq of Glioblastoma stem cells
Study
EGAS00001003070
-
Tumor-associated preferred end coordinates and somatic variants as signatures of circulating tumor DNA
Study
EGAS00001003160
-
Exome sequencing of advanced hepatocellular carcinoma
Study
EGAS00001003130
-
DNA Methylation-based diagnostic biomarkers for ESCC in Han Chinese population
Study
EGAS00001003158
-
CD74-NRG1 fusions in lung adenocarcinoma
Study
EGAS00001000653
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Colorectal
Study
EGAS00001003774
-
Recurrent epimutations activate gene body promoters in primary glioblastoma
Study
EGAS00001000685
-
Chondrosarcoma_Exome_
Study
EGAS00001000038
-
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Study
EGAS00001003178
-
The molecular landscape of glioma in patients with Neurofibromatosis 1.
Study
EGAS00001003186
-
Balanced_Ependymoma
Study
EGAS00001000174
-
Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
Study
EGAS00001004349
-
WES used for direct identification of clinically relevant neoepitopes presented on native human melanoma tissue by mass spectrometry
Study
EGAS00001002050
-
RNAseq___Discovery_of_resistance_mechanisms_to_the_BRAF_inhibitor_vemurafenib_in_metastatic_BRAF_mutant_melanoma
Study
EGAS00001000813
-
Diverse modes of genomic alterations in hepatocellular carcinoma
Study
EGAS00001000824
-
Genomic analysis of Smoothened inhibitor resistance in basal cell carcinoma
Study
EGAS00001000845
-
Genetic landscape of relapsed DLBCL
Study
EGAS00001001553
-
Dissection of the molecular complexity of colorectal cancer in pre-clinical models identifies predictive signatures of sensitivity to EGFR inhibitors
Study
EGAS00001001752
-
Genetic Landscape of Esophageal Squamous Cell Carcinoma Defined by Exome Sequencing on Chinese Patient Cohort and Cell Lines
Study
EGAS00001000932
-
Alternative splicing in Shh-MB
Study
EGAS00001003220
-
Genomics of enteropathy associated T cell lymphoma (EATL)
Study
EGAS00001001954
-
Whole Exome Sequencing in Multiple Myeloma
Study
EGAS00001003227
-
The genomic landscape of Burkitt Lymphoma
Study
EGAS00001002198
-
Lindsey E. Jones et al. Patient-derived cells from recurrent tumors that model the evolution of IDH-mutant glioma. Neuro-Oncology Advances, 2020. We established robust, versatile, and well-characterized Patient Derived Cells (PDC) of an IDH1-mutant astrocytoma and an IDH1-mutant oligodendroglioma that represents defined evolutionary stages of chemotherapy-induced hypermutation. The PDCs retain tumor subtype defining features over time as well as classic hallmarks of cancer, including anchorage independent growth and cell immortality. The integrated phylogenies composed of PDCs,single-cell-derived PDCs, patient-derived xenografts, and corresponding spatiotemporal tumor tissue samples also provide new insight into the clonality, evolutionary pattern, and immense mutational load of hypermutated IDH mutant gliomas.
Study
EGAS00001003992
-
Xenograft_Sequencing
Study
EGAS00001000140
-
An RCOR1 loss-associated gene expression signature identifies a prognostically significant DLBCL subgroup
Study
EGAS00001001000
-
Osteosarcoma_Whole_Genome
Study
EGAS00001000147
-
Adeno-associated virus in the liver: natural history and consequences in tumor development
Study
EGAS00001003310
-
Poly(A) RNA sequencing of hepatocellular carcinoma tumors and their matched noncancerous liver tissues
Study
EGAS00001002337
-
MYCN Amplification and ATRX Mutations are Incompatible in Neuroblastoma
Study
EGAS00001003257
-
RNAseq_of_patients_with_Ewings_sarcoma
Study
EGAS00001000267
-
Whole genome and RNA sequencing of paediatric glioblastoma in the ICGC PedBrain project
Study
EGAS00001001139
-
MethylationEPIC BeadChip samples of pre- and post-5ZA-treated head and neck cancer patients refractory to anto-PD-1 therapy
Study
EGAS00001007998
-
Whole Tumor spatial heterogeneity in metastatic melanoma
Study
EGAS00001003292
-
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Study
EGAS00001003306
-
Single-cell RNA-sequencing of a multi-region pleural mesothelioma case
Study
EGAS00001008062
-
Genomic analysis of HPV positive versus HPV negative esophageal adenocarcinoma
Study
EGAS00001001340
-
Fibroblast heterogeneity and immunosuppressive environment in Human breast cancer
Study
EGAS00001002508
-
WES of clonally related neuroblastoma and teratoma
Study
EGAS00001005116
-
Genome-wide identification of distinct miRNA-mRNA target regulation pairs in Non-Hodgkin lymphomas: a report from the ICGC MMML-Seq consortium
Study
EGAS00001001394
-
Precursor_lesions__clonal_architecture_and_relapse_in_Wilms_nephroblastoma
Study
EGAS00001001422